{'fraction_non_alphanumeric': 0.022546419098143235, 'fraction_numerical': 0.010610079575596816, 'mean_word_length': 5.452991452991453, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
GLYCATED HAEMOGLOBIN (HBA1C) AND ITS ASSOCIATION WITH ISCHAEMIC STROKE IN DIABETICS AND NON- DIABETICS.

Stroke is a condition that results in high mortality rates and severe disabilities. Stroke is expected to be the second most important cause of mortality worldwide by 2020. Most stroke survivors can and do experience improvements in their functional abilities, but the amount, rate, timing, pattern, type, and ultimate outcome of the improvements differ across patients and situations.1 Stroke severity and patient age are the main predictors of stroke outcome in the acute phase 2. Additional important predictors include functional status prior to stroke, presence of comorbid medical conditions, etiologies and the vascular territories affected.3